SOFA-2 reclassification: data availability and incremental prognostic value - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Reevaluation of SOFA-2: Assessing Data Accessibility and Enhanced Prognostic Insights

  • By

  • Dilek Kuzukıran Kocataş

  • August 20, 2026

Share

  • 1

    SOFA-2 shows improved data availability for respiratory and neurologic components compared to the original SOFA score.

  • 2

    The unequal data availability between SOFA and SOFA-2 may influence observed reclassification and mortality outcomes.

  • 3

    The methodology for inverse probability weighting in the study lacks clarity regarding the covariates used and their implications.

  • 4

    Reciprocal exact-matching analyses indicate an association between score discordance and mortality but do not confirm incremental prognostic value.

  • 5

    Further analyses are needed to assess the impact of differential data availability and to evaluate the prognostic performance of SOFA-2.

Original Source(s)

SOFA-2 reclassification: data availability and incremental prognostic value

  • by Dilek Kuzukıran Kocataş

  • August 20, 2026

Related Content

To guide or not to guide percutaneous dilational tracheostomy? broncoscope, ultrasound or nothing?

Hemodynamic profile of neonatal fungal sepsis with insights into the disease spectrum: a retrospective study

How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages

“There is incredible uncertainty in drug dosing.”